Chiltern opens Office in Budapest, Hungary
pharmafile | December 7, 2009 | News story | Research and Development |
Dr. Attila Lorinczi will lead this operation. Dr. Lorinczi is a member of the Hungarian Medical Society and the Society of Hungarian Urologists. Dr. Lorinczi has broad experience in the pharmaceutical industry spanning over 13 years, most recently as a clinical operations manager.
“Hungary and the CEE region continue to provide excellent quality data and good patient recruitment rates,” Attila commented. “We expect this to grow further due to the knowledge and expertise of Hungarian investigators and the availability of quality staff.”
“Chiltern continues to expand following our recent opening of an office in Belgium,” explained Lewis Cameron, Chiltern Executive Vice President for Europe. “Central and Eastern Europe continues to be a key focus for our clinical trials and Hungary is an important component of this region. We are delighted to show our continual regional growth in line with our strategy for increased global coverage.”






